Articles tagged with Glucose
A new process converts polycotton textile waste into glucose, a key bio-based feedstock, and separates polyester fibers for reprocessing. The technique is scalable and cost-effective, offering a viable solution to textile waste recycling.
A retrospective cohort study of 44,000 individuals found associations between baseline fasting glucose levels, age, sex, and body mass index with the development of diabetes. The study highlights individual variation in diabetes risk according to commonly measured clinical variables, suggesting potential for targeted interventions.
Researchers found that time in safe blood-sugar range can predict diabetes complications as accurately as hemoglobin A1c levels. The study used advanced machine learning techniques to analyze landmark diabetes data from the DCCT trial.
Kyushu University researchers create a microwave flow reaction device that converts complex polysaccharides into simple monosaccharides, producing glucose. The device utilizes a continuous-flow hydrolysis process, where cellobiose is passed through a sulfonated carbon catalyst heated using microwaves.
Researchers from Kumamoto University identified SerpinA1 as a key regulator in combating obesity and enhancing glucose metabolism. The study found that activating brown adipose tissue could pave the way for innovative treatments for diabetes and metabolic disorders.
Researchers at Karolinska Institutet used AI to analyze brain images from 70-year-olds and found that factors like inflammation and high glucose levels are associated with an older-looking brain. A healthy lifestyle, on the other hand, was linked to brains with a younger appearance.
A new Northwestern Medicine study reveals how metformin lowers glucose levels by targeting mitochondrial complex I in cells. The drug also improves COVID outcomes and reduces inflammation, suggesting that mitochondrial complex I inhibition may be a unifying mechanism behind its diverse effects.
A UK study published in Diabetic Medicine found that over half of pregnant women with gestational diabetes were undiagnosed due to slow NHS blood test processing. Faster blood processing identified additional cases, leading to improved health outcomes for mothers and babies.
Population-level improvements in total cholesterol and triglyceride levels slowed, while adverse trends in glucose levels accelerated in more recent US birth cohorts. Public health initiatives targeting antecedent health behaviors are needed to improve cardiometabolic health across generations.
The novel compound HPH-15 outperforms metformin by activating AMPK at lower doses, improving glucose uptake and reducing fat accumulation in high-fat diet-induced obese mice. Additionally, it exhibits antifibrotic properties, potentially addressing liver fibrosis.
A study published in Nature reveals that dietary fructose promotes tumor growth in animal models of melanoma, breast cancer, and cervical cancer. The liver converts fructose into usable nutrients for cancer cells, a finding that could lead to new treatment avenues.
A recent study published in Nutrition & Diabetes found that consuming over 45% of daily calorie intake after 5 p.m. is associated with increased glucose levels, regardless of individual weight or body fat composition. This can lead to a higher risk of type 2 diabetes, cardiovascular disease, and chronic inflammation.
A recent study published in PLOS ONE utilized TāStation to refute the glucose transport taste signaling hypothesis, showing that all sweet taste signaling occurs exclusively through the TAS1R2/TAS1R3 receptor. The research demonstrates the analytical power of TāStation in resolving complex scientific problems.
Prescription rates of sodium-glucose cotransporter-2 inhibitors increased substantially within 2 years after publication of clinical trial evidence documenting benefit. The study highlights the need to understand strategies used by higher prescribing centers to increase SGLT2i adoption.
Researchers at POSTECH have identified GLUT3 as essential for the suppressive function of regulatory T cells in tumor microenvironments, which can be targeted for cancer immunotherapy. The team's findings highlight the critical role of GLUT3 in regulating protein modifications that sustain immune suppression within tumors.
Researchers from Texas A&M University synthesized research findings to improve medical devices and therapy success rates. The review emphasizes the need to understand macrophage cell behavior to develop targeted immunotherapy treatments.
A USTC team led by Researcher LIU Ji unveiled an adrenal-independent pathway, the hypothalamus-sympathetic-liver (HSL) axis, to mediate stress-induced glucose release. This new pathway regulates glucose homeostasis and provides potential therapeutic targets for stress-related metabolic disorders.
Researchers developed a screening technique to filter out low-quality data in wearable sensors, improving the performance of smartwatches for noninvasive blood glucose estimation. The approach enhances accuracy by discarding data with high phase errors and approximating missing values.
Researchers discovered that tuberculosis alters liver metabolism and can push patients towards metabolic disease like diabetes. The study suggests undiagnosed TB could be a significant contributor to metabolic health issues.
Researchers developed glucose-responsive micelles that encapsulate and protect glucagon, releasing it when blood sugar levels drop below a certain threshold. The micelles prevented hypoglycemia in mouse trials, achieving normal blood sugar levels within 40 minutes.
A randomized controlled trial found that time-restricted eating (TRE) led to greater improvements in glucose control, weight loss, and fat reduction compared to standard nutrition counseling in adults with metabolic syndrome. TRE resulted in a lower risk of muscle mass loss during weight loss.
Researchers at University of Gothenburg propose inhibiting somatostatin to restore glucagon release and prevent dangerous blood sugar levels. This approach has the potential to save lives and is supported by experimental results in mice with type 1 diabetes.
Scientists identify PICALM as a key player in regulating glucose homeostasis and insulin signaling in adipocytes. Reduced expression of PICALM improves insulin sensitivity and glucose transport, holding promise for new therapeutic approaches for type 2 diabetes and obesity.
Non-diabetic adults who use continuous glucose monitoring sensors spend significantly more time with elevated glucose levels than previously thought. The study found that normoglycemic participants experienced glucose levels above 140mg/dL for an average of three hours per day.
A new large-scale longitudinal study will investigate the environmental, lifestyle, social, and clinical factors affecting brain development in children with type 1 diabetes. The five-year study aims to refine clinical guidelines and targeted treatments for children with diabetes.
Scientists at Shanghai Jiao Tong University created a novel glucose sensing system using heterogeneous CuxO nano skeletons from electronic waste. The method employed laser-induced transfer techniques to fabricate electrodes with high sensitivity and stability, achieving detection limits of 0.34 μM.
The wearable device monitors vital chemical levels in fingertip sweat, fueling its own energy and powering a suite of sensors. It can track glucose, vitamins, lactate, and levodopa levels without requiring physical activity or stimuli, offering a reliable health monitoring solution.
A new study published in Scientific Reports confirms a linear relationship between blood glucose levels and voice fundamental frequency, suggesting potential for voice-based glucose monitoring. Researchers at Klick Labs used vocal biomarkers and AI to detect Type 2 diabetes with high accuracy.
Researchers find that unabsorbed dietary polyphenols can reduce the risk of type II diabetes by regulating blood glucose levels and appetite through secretion of gastrointestinal hormones. Polyphenol-mediated binding and activation of T2R promotes the release of incretins, which regulate insulin secretion and food intake.
A new study found that females' and males' muscles handle glucose and fatty acids differently, but regular physical activity cancels out these differences and triggers similar beneficial metabolic changes in both sexes. This research has important implications for preventing type 2 diabetes.
A new study by the Cleveland Clinic found that consuming foods with erythritol increases the risk of cardiovascular events such as heart attack and stroke. The artificial sweetener makes platelets more active, which can raise blood clot risks. This research adds to evidence that erythritol may not be as safe as previously thought.
A study published in Cardiovascular Diabetology found that higher blood glucose levels at admission significantly increase the risk of a poor functional prognosis or death within three months of an ischemic stroke. The study revealed that even a 10% increase in glucose levels raises the risk by 7%, and mortality risk by 88%.
A new study published in Cell Reports Medicine found that a ketogenic diet can reduce beneficial gut bacteria and increase unfavorable fats in the blood. The diet, which is high in fat and low in carbohydrates, may have long-term health implications such as increased risk of heart disease and stroke.
Experts advocate for incorporating normalization of blood sugar regulation into diabetes prevention strategies. Studies show that weight loss-induced prediabetes remission can significantly reduce the risk of developing type 2 diabetes, especially when combined with lifestyle changes.
Researchers analyzed over 1.5 million patient records to find that metformin and SGLT-2 inhibitors lowered dementia and Alzheimer's disease risks compared to other antidiabetic drugs. The study suggests individualized treatment approaches considering patient-specific factors for optimal diabetes management.
Researchers found that combining sodium glucose co-transporter 2 inhibitors and glucagon-like peptide-1 receptor agonists reduces the risk of major adverse cardiovascular events and chronic kidney disease progression by 11% and 33%, respectively. The study suggests using this combination to further improve outcomes in patients with typ...
The NTU team created a compact and flexible light-based sensing device, like a plaster, to provide highly accurate biomarker readings within minutes. The device detects glucose, lactate, and urea levels in sweat with ultra-high sensitivity and dynamic range.
Researchers found that individual responses to proteins and fats can drive insulin production, challenging the long-held belief that fats have negligible effects on insulin release. This study has implications for tailored dietary guidance to manage blood sugar and insulin levels in individuals with diabetes or those at risk.
Researchers developed a one-dimensional convolutional neural network (1D CNN) to compensate for errors due to sample location variations. The model achieved high accuracy, reducing mean absolute error to 0.695% and mean squared error to 0.876%.
A new study found that strawberry intake significantly influenced flow-mediated dilation, suggesting a dose-response toward higher CVD risk reduction. The study also suggested a 8-times reduced CVD risk with daily strawberry consumption compared to the control group.
A wearable health monitor developed by Washington State University researchers can accurately measure levels of important biochemicals in sweat during physical exercise. The device has the potential to track health conditions and diagnose common diseases, including diabetes, gout, kidney disease, and heart disease.
A recent study has identified three subgroups of gestational diabetes with different treatment needs, enabling personalized therapy and reducing complications for mothers and children. The analysis used cluster methods and machine learning to analyze data from 2682 women with gestational diabetes.
A study found that adding dapagliflozin to standard care did not improve clinical outcomes, but wide confidence intervals suggest potential benefits or harms. The results did not support the use of dapagliflozin in critically ill patients with acute organ dysfunction.
A potential new strategy for reducing diabetes risk associated with antipsychotic medications involves co-administering drugs that block dopamine receptors in the brain alongside those that stop these same receptors in the pancreas. This approach may limit metabolic side effects and improve glucose metabolism.
A new study led by researchers at UC San Francisco found that a virtual emotion-centered program called TunedIn can reduce diabetes distress by half and improve glucose control. The program incorporates elements of Acceptance and Commitment Therapy and was delivered virtually to 276 adults with Type 1 diabetes.
Aging human pancreatic beta cells display features of senescence but maintain elevated levels of genes crucial for function and exhibit an ability to release insulin in response to glucose. This sheds light on the potential role of aging beta cells in immune regulation and their relevance to autoimmune reactions in type 1 diabetes.
Researchers at the State University of Campinas found that daily consumption of jaboticaba peel improved glucose metabolism even after meals. The study showed lower post-prandial glycemia and less inflammation in volunteers with obesity and metabolic syndrome.
Researchers at Ben-Gurion University have discovered a molecular mechanism that enables cancer cells to survive under glucose starvation. By targeting this pathway, they aim to develop a molecule that can block the survival of tumor cells while leaving healthy cells unaffected.
A new study published in Nature Metabolism challenges the common perception that high lactate levels are bad for athletes. Lactate is found to be a normal product of metabolic activity, and it plays a crucial role in managing glucose levels after consuming carbohydrates.
Research links higher blood sugar levels at gestational diabetes diagnosis to complications in newborns, including low blood sugar and large birth weight. Women diagnosed with gestational diabetes are also at a higher risk of developing type 2 diabetes after birth.
The study reveals that cellobiose fragments can bind to the tunnel's back door and block subsequent cellulose molecules, as well as bind to Cel7A near the front door, preventing enzyme binding. New methods could be developed to fine-tune this process, improving biofuel production efficiency.
Neotame has been shown to cause previously healthy gut bacteria to become diseased and invade the gut wall, potentially leading to irritable bowel syndrome and sepsis. The study also found a breakdown of the epithelial barrier, which forms part of the gut wall.
A study by Prof. LI Yu and colleagues reveals that glucose signals are essential for regulating thermogenic activity in beige adipocytes, which emerge in response to cold stress. The researchers identified the transcription factor CREB/ATF bZIP (CREBZF) as a key mediator of glucose effects.
Researchers found that CMS121 reduced body weight gain by 40% and improved glucose and lipid indexes in aging mice. The compound also showed anti-inflammatory effects and increased mitochondrial biogenesis, suggesting potential therapeutic applications for metabolic diseases.
A review of mitochondrial energy metabolism in diabetic cardiomyopathy reveals disrupted dynamics and oxidative stress as key triggers. Targeted therapies, such as antioxidants and ketogenic diets, show promise in combating this debilitating condition.
A massive study of over 200,000 participants found associations between metabolic dysregulation and long-term risk of depression, anxiety, and stress-related disorders. These findings suggest that individuals with metabolic issues may require closer follow-up for psychiatric diagnosis prevention.
Researchers at NIST have developed a method using cellphone magnetometers to rapidly and cheaply measure biomedical properties for monitoring or diagnosing diseases, including glucose levels in saliva. The technique has the potential to detect environmental toxins and measure biomarkers such as histamines with high sensitivity.
A study published in PLOS ONE found that high fat/low protein diets in rats during pregnancy and postnatally can cause altered glucose control and other maladaptive metabolic changes in their offspring. The researchers also discovered disruptions in circadian rhythm programming of energy metabolites through adulthood.
Researchers have identified PDE4B as a potential target for treating Alzheimer's disease, where reducing its activity shows promise in improving memory and glucose metabolism. The study suggests that this approach may also protect against other forms of dementia, such as Huntington's disease.
A new study evaluates the use of tirzepatide in overweight/obese adults with type 1 diabetes, showing significant weight loss and improved glucose control. Tirzepatide also reduces insulin dose and increases time-in-range on continuous glucose monitoring.